Chief Scientific OfficerVascular TherapiesNEW YORK, New York
VESS18 - Developing SirogenTM - A Sirolimus Formulation for Intraoperative Periadventitial Delivery: Bench to Bedside
Wednesday, June 19, 20244:07 PM – 4:12 PM CT